GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Evoq Remedies Ltd (BOM:543500) » Definitions » Net Income Including Noncontrolling Interests

Evoq Remedies (BOM:543500) Net Income Including Noncontrolling Interests : ₹4.52 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Evoq Remedies Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Evoq Remedies's Net Income Including Noncontrolling Interests for the six months ended in Mar. 2024 was ₹4.02 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 was ₹4.52 Mil.

Evoq Remedies Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Evoq Remedies's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evoq Remedies Net Income Including Noncontrolling Interests Chart

Evoq Remedies Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial - 7.15 10.91 16.19 4.52

Evoq Remedies Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only 3.60 3.06 13.13 0.50 4.02

Evoq Remedies Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹4.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evoq Remedies Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Evoq Remedies's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Evoq Remedies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Evoq Remedies Ltd (BOM:543500) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
NSE:MONOPHARMA BOM:543616 BOM:514330 BOM:543594 BOM:501477 LLY JNJ MRK ABBV XSWX:ROG LSE:AZN XSWX:NOVN PFE AMGN XPAR:SAN BMY GILD LSE:GSK TSE:4568 TSE:4519
Traded in Other Exchanges
N/A
Address
Science City Road, A-1106, Empire Business Hub, Near AUDA Water Tank, Sola, Ahmedabad, GJ, IND, 380060
Website
http://www.evoqremedies.com
Evoq Remedies Ltd is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, calcium, multivitamins, injections and others. It operates in a single segment that is Pharmaceutical Trading.

Evoq Remedies Headlines

No Headlines